Related Experiment Videos
Expression of mitogenically active human recombinant platelet-derived growth factor A-chain
J M Kaplow1, B D Tong, D R Hurwitz
1Rorer Biotechnology, Inc., King of Prussia, PA 19406.
Summary
Researchers created a continuous source of human platelet-derived growth factor (PDGF) A-chain protein. This recombinant PDGF A-chain is mitogenically active and may offer new clinical applications, such as wound healing.
Area of Science:
- Molecular Biology
- Biochemistry
- Cell Biology
Background:
- Platelet-derived growth factor (PDGF) is crucial for cell growth and differentiation.
- Natural PDGF A-chain dimers are produced in minute quantities by specific tissues.
- A consistent and abundant source of PDGF A-chain is needed for research and clinical applications.
Purpose of the Study:
- To develop a method for the continuous and abundant production of recombinant human PDGF A-chain.
- To confirm the biological activity and structural integrity of the produced PDGF A-chain.
- To explore the potential of recombinant PDGF A-chain in clinical settings like wound healing.
Main Methods:
- Cotransfection of expression vectors for human PDGF A-chain and murine dihydrofolate reductase (DHFR) into DHFR-deficient Chinese hamster ovary cells.
- Methotrexate-induced coamplification to enhance PDGF A-chain expression.
- Immunoprecipitation and metabolic labeling to detect and characterize the recombinant protein.
- Analysis of protein structure under reducing conditions to confirm homodimeric nature.
Main Results:
- Successful coamplification led to increased levels of PDGF A-chain DNA, RNA, and protein.
- A 30,500 Mr homodimeric protein was immunoprecipitated using PDGF antisera.
- The recombinant PDGF A-chain protein demonstrated mitogenic activity.
- The produced protein confirmed to be a homodimer composed of two polypeptides.
Conclusions:
- The study established a system for constitutive secretion of recombinant PDGF A-chain.
- The recombinant PDGF A-chain is biologically active and structurally confirmed as a homodimer.
- This approach provides a scalable source of PDGF A-chain for further research and potential clinical use in wound healing.